Cancer Family
Pleural Mesothelial Neoplasm
CI-CAN-00000322Explore in graph →
Non-malignant34 active trials4 approved drugs6 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000322Explore in graph →
Clinical trials
157 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01353482 | A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma(MESO-02) | withdrawn | Phase 1 / Phase 2 | 0 | University College, LondonOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01343264 | Trimodality Therapy for Malignant Pleural Mesothelioma | unknown | — | 200 | HSK WiesbadenOTHER | 1 | Apr 28, 2011 | clinicaltrials |
| NCT01243632 | Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma Treatment | completed | Phase 2 | 78 | Institute of Oncology LjubljanaOTHER | 1 | Nov 18, 2010 | clinicaltrials |
| NCT00280982 | Dendritic Cell-based Immunotherapy in Mesothelioma | completed | Phase 1 | 10 | Erasmus Medical CenterOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00272558 | Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma | completed | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00886028 | Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma | unknown | Phase 2 | 31 | National Institute of CancerologíaOTHER_GOV | 1 | Apr 22, 2009 | clinicaltrials |
| NCT00386815 | Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma | completed | Phase 2 | 20 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 11, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Mar 22, 2012source: clinicaltrials